Hakon Bergheim joined Anaxiom Corporation in March 2025 as President and Chief Executive Officer. He has over 15 years of experience in medical devices across both start-up and publicly traded companies. 

Prior to Anaxiom, Hakon served as Chief Operating Officer at Adagio Medical, a leading innovator in the treatment of cardiac arrhythmias. 

He holds a Bachelor of Science in Chemical Engineering from UC Irvine and an MBA from the University of Southern California.